Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rahul Singhvi currently holds 66,350 shares of ImmunoCellular Therapeutics, Ltd. (IMUC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rahul Singhvi has been a net seller of IMUC stock. They have purchased $3.3K and sold $772.9K worth of shares.
Rahul Singhvi's most recent insider trade was on Jun 17, 2026, when they sold 66,350 shares at $0.00 per share.
Rahul Singhvi serves as Executive at ImmunoCellular Therapeutics, Ltd. (IMUC). They have executed 22 insider transactions totaling $776.2K over their tenure at the company.
Rahul Singhvi holds the position of Executive at ImmunoCellular Therapeutics, Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Rahul Singhvi has shown a selling trading pattern, with $3.3K in total purchases and $772.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Rahul Singhvi was on Jul 1, 2009, when they sold $274.5K worth of NVAX shares. This transaction involved 90,900 shares at $3.02 per share.
Rahul Singhvi currently owns 66,350 shares of ImmunoCellular Therapeutics, Ltd. (IMUC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rahul Singhvi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rahul Singhvi has 22 Form 4 filings on record as an insider at ImmunoCellular Therapeutics, Ltd..
Set alerts for Rahul Singhvi and 40,000+ other insiders.